Stockreport

FATE Presents Encourgaing Data From Lupus Study, Stock Gains [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Data showed that the first patient suffering from active lupus nephritis (LN) and treated with FT819 had favorable clinical experience, achieved drug-free clinical remi [Read more]